The present invention relates to methods of preventing or treating a mammal with a viral-induced disorder. The method involves administering to the mammal a therapeutically effective amount of a compound represented by Formula I, as shown below: ##STR00001## or a pharmaceutically acceptable salt thereof, with X, R.sub.0, and R.sub.1 defined herein, under conditions effective to prevent or treat the viral-induced disorder.

 
Web www.patentalert.com

< Erythropoietin: remodeling and glycoconjugation of erythropoietin

> Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders

> IL-12 modulatory compounds

~ 00597